- Stocks
- Healthcare
- NYSE: LLY

Price (delayed)

$206.14

Market cap

$197.19B

P/E Ratio

33.52

Dividend/share

$2.96

EPS

$6.15

Enterprise value

$210.52B

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded

The equity has increased by 43% year-on-year and by 18% since the previous quarter

The quick ratio has increased by 20% year-on-year and by 16% since the previous quarter

The P/E is 52% above the last 4 quarters average of 22.0 but 21% below the 5-year quarterly average of 42.3

The net income has contracted by 30% YoY

The EPS has decreased by 25% YoY

What are the main financial stats of LLY

Market
Valuations
Earnings

Shares outstanding

956.58M

Market cap

$197.19B

Enterprise value

$210.52B

Price to earnings (P/E)

33.52

Price to book (P/B)

40.85

Price to sales (P/S)

8.06

EV/EBIT

32.77

EV/EBITDA

27.27

EV/Sales

9.07

Revenue

$23.21B

EBIT

$6.42B

EBITDA

$7.72B

Free cash flow

$5.39B

Per share
Balance sheet
Liquidity

EPS

$6.15

Free cash flow per share

$5.94

Book value per share

$5.05

Revenue per share

$25.59

TBVPS

$35.97

Total assets

$43.95B

Total liabilities

$38.95B

Debt

$16.92B

Equity

$4.83B

Working capital

$4.26B

Debt to equity

3.51

Current ratio

1.36

Quick ratio

0.79

Net debt/EBITDA

1.73

Margins
Efficiency
Dividend

EBITDA margin

33.3%

Gross margin

78.3%

Net margin

24%

Operating margin

27.7%

Return on assets

13.4%

Return on equity

152.6%

Return on invested capital

19.9%

Return on capital employed

20.1%

Return on sales

27.7%

Dividend yield

1.44%

DPS

$2.96

Payout ratio

48.1%

How has the ELI LILLY stock price performed over time

Intraday

1.87%

1 week

8.06%

1 month

23.64%

1 year

45.62%

YTD

22.09%

QTD

22.09%

How have ELI LILLY's revenue and profit performed over time

Revenue

$23.21B

Gross profit

$18.17B

Operating income

$6.42B

Net income

$5.57B

Gross margin

78.3%

Net margin

24%

LLY's operating income is up by 42% year-on-year

ELI LILLY's net margin has decreased by 34% YoY and by 2% from the previous quarter

ELI LILLY's operating margin has increased by 33% YoY

The net income has contracted by 30% YoY

What is ELI LILLY's growth rate over time

What is ELI LILLY stock price valuation

P/E

33.52

P/B

40.85

P/S

8.06

EV/EBIT

32.77

EV/EBITDA

27.27

EV/Sales

9.07

The P/E is 52% above the last 4 quarters average of 22.0 but 21% below the 5-year quarterly average of 42.3

The EPS has decreased by 25% YoY

LLY's P/B is 111% above its 5-year quarterly average of 19.4 and 2.6% above its last 4 quarters average of 39.8

The equity has increased by 43% year-on-year and by 18% since the previous quarter

The stock's price to sales (P/S) is 68% more than its 5-year quarterly average of 4.8 and 39% more than its last 4 quarters average of 5.8

ELI LILLY's revenue has increased by 6% YoY

How efficient is ELI LILLY business performance

The ROA has contracted by 33% YoY and by 4.3% from the previous quarter

The ROS has decreased by 26% YoY

The ROIC has contracted by 25% YoY

The company's return on equity fell by 11% YoY and by 11% QoQ

What is LLY's dividend history

DPS

$2.96

Dividend yield

1.44%

Payout ratio

48.1%

Recent dividends

How did ELI LILLY financials performed over time

LLY's total assets is 13% greater than its total liabilities

The quick ratio has increased by 20% year-on-year and by 16% since the previous quarter

ELI LILLY's current ratio has increased by 16% YoY and by 11% from the previous quarter

The equity has increased by 43% year-on-year and by 18% since the previous quarter

The company's debt to equity fell by 24% YoY and by 12% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.